Skip to content

Nurix Therapeutics, Inc. NRIX Lessee, Operating Lease, Liability, Tenant Improvement Allowance

Lessee, Operating Lease, Liability, Tenant Improvement Allowance at other companies

Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$592K+261%
Moelis & Company logo
Moelis & CompanyMC
$1.2M-76.0%
Match Group logo
Match GroupMTCH
$3.86M
AZZ logo
AZZAZZ
$60.65M+127%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
-$227K-66.9%
Hubbell logo
HubbellHUBB
$39.5M+3.4%

Other financials

Income statement

See full
Revenue$6.3M-66.1%
Operating income-$92.5M-47.1%
Net income-$87.2M-54.7%
EPS (diluted)-$0.79-17.9%

Balance sheet

See full
Cash & equivalents$72.2M-6.1%
Total debt$58.7M+120%
Total equity$480.9M0.0%
Total assets$636.1M+3.4%

Cash flow

See full
Operating cash flow-$71.9M-17.7%
CapEx$1.0M-70.0%
Free cash flow-$73.0M-13.0%

Valuation

See full
Market cap$1.95B+40.1%
Enterprise value$1.94B+45.1%
P/S27.2×+2.5×

Profitability

See full
Operating margin-439.3%+35.3pp
Net margin-411.4%+52.7pp
FCF margin-378.7%+24.1pp

Returns & leverage

See full
Return on equity-61.4%-2.5pp
Debt / equity0.1×+0.1×
Current ratio-0.3×

Where this comes from

Reported directly by Nurix Therapeutics, Inc. in its filing.

Tagged under the XBRL concept nrix:LesseeOperatingLeaseLiabilityTenantImprovementAllowance.

The official record: Nurix Therapeutics, Inc.’s 10-K, filed January 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nurix Therapeutics, Inc.'s lessee, operating lease, liability, tenant improvement allowance.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nurix Therapeutics, Inc.'s lessee, operating lease, liability, tenant improvement allowance?
Nurix Therapeutics, Inc. (NRIX) reported lessee, operating lease, liability, tenant improvement allowance of $8M in Q3 2025.
What does lessee, operating lease, liability, tenant improvement allowance mean?
Reflects the portion of lease liabilities associated with tenant improvement allowances provided by landlords. It represents a financing arrangement where the landlord funds facility build-outs, which is then amortized over the lease term.